Alembic Pharma rises after USFDA approvals for drugs
Alembic Pharmaceuticals | April 25, 2017
Alembic Pharmaceuticals gained 1.87% to Rs 616.45 at 14:05 IST on BSE after the company received USFDA final approvals for Olmesartan Medoxomil Tablets and Olmesartan Medoxomil with Hydrochlorothiazide Tablets.